Scanlan Sean F.
Officer at TMCI
- Sold, on record
- $5.4M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Mar 17, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TMCITREACE MEDICAL CONCEPTS, INC.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TMCIUnusualMar 2, 2022 2022
Sold 25,000 shares at $20.82 ($521k)
Scanlan Sean F., SVP, Marketing
Sold 100% of holdings ($521k position)0 shares left1x usual sizeFiling
- 2 Form 4 sale TMCIUnusualNov 14, 2022 +257 days
Sold 25,000 shares at $24.27 ($607k)
Scanlan Sean F., SVP, Marketing
Sold 71.5% of holdings ($849k position)9,975 shares left1x usual sizeFiling
- 3 Form 4 sale TMCIUnusualJan 12, 2023 +59 days
Sold 25,000 shares at $25.57 ($639k)
Scanlan Sean F., Chief Innovation Officer
Sold 71.5% of holdings ($894k position)9,975 shares left1x usual sizeFiling
- 4 Form 4 sale TMCIUnusualFeb 15, 2023 +34 days
Sold 25,000 shares at $21.69 ($542k)
Scanlan Sean F., Chief Innovation Officer
Sold 71.5% of holdings ($759k position)9,975 shares left1x usual sizeFiling
- 5 Form 4 sale TMCIPlan not statedMar 9, 2023 +22 days
Sold 505 shares at $24.41 ($12k)
Scanlan Sean F., Chief Innovation Officer
Sold 5.1% of holdings ($243k position)9,470 shares left0x usual sizeFiling
- 6 Form 4 sale TMCIUnusualMay 16, 2023 +68 days
Sold 25,000 shares at $25.44 ($636k)
Scanlan Sean F., Chief Innovation Officer
No 10b5-1 planSold 43.6% of holdings ($1.5M position)32,395 shares left1x usual sizeFiling
- 7 Form 144 notice TMCINoticeMar 17, 2025 +671 days
Filed to sell 50,000 shares ($398k)
Scanlan Sean F., Officer
10b5-1 planFiling
- 8 Form 4 sale TMCIRoutineMar 17, 2025 same day
Sold 50,000 shares at $7.97 ($399k)
Scanlan Sean F., Chief Innovation Officer
10b5-1 planSold 12.1% of holdings ($3.3M position)364,081 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | Mar 19, 2025 | TMCI | Chief Innovation Officer | Form 4 sale | 50,000 | $399k | 12.1% | Routine | SEC |
| Mar 17, 2025 | Mar 17, 2025 | TMCI | Officer | Form 144 notice | 50,000 | $398k | Notice | SEC | |
| May 16, 2023 | May 18, 2023 | TMCI | Chief Innovation Officer | Form 4 sale | 25,000 | $636k | 43.6% | Unusual | SEC |
| Mar 9, 2023 | Mar 10, 2023 | TMCI | Chief Innovation Officer | Form 4 sale | 505 | $12k | 5.1% | Plan not stated | SEC |
| Feb 15, 2023 | Feb 17, 2023 | TMCI | Chief Innovation Officer | Form 4 sale | 25,000 | $542k | 71.5% | Unusual | SEC |
| Jan 12, 2023 | Jan 13, 2023 | TMCI | Chief Innovation Officer | Form 4 sale | 25,000 | $639k | 71.5% | Unusual | SEC |
| Nov 14, 2022 | Nov 16, 2022 | TMCI | SVP, Marketing | Form 4 sale | 25,000 | $607k | 71.5% | Unusual | SEC |
| Mar 2, 2022 | Mar 4, 2022 | TMCI | SVP, Marketing | Form 4 sale | 25,000 | $521k | 100.0% | Unusual | SEC |
| Feb 9, 2022 | Feb 10, 2022 | TMCI | SVP, Marketing | Form 4 sale | 25,000 | $501k | 100.0% | Unusual | SEC |
| Jan 11, 2022 | Jan 12, 2022 | TMCI | SVP, Marketing | Form 4 sale | 47,700 | $961k | 100.0% | Unusual | SEC |
| Jan 5, 2022 | Jan 5, 2022 | TMCI | SVP, Marketing | Form 4 sale | 2,300 | $46k | 100.0% | Unusual | SEC |
| Nov 10, 2021 | Nov 12, 2021 | TMCI | SVP, Marketing | Form 4 sale | 25,000 | $539k | 100.0% | Unusual | SEC |